CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.

The CRISPR-led gene-editing revolution is set to begin next month in its first ever trial in humans. The small phase 1 trial, to take place in China ... The CRISPR-Cas9 platform will be used ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...

In a new development, researchers have successfully created an efficient two-line system for hybrid seed production in ...

Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

New CRISPR tool enables more seamless gene editing -- and improved disease modeling. ScienceDaily . Retrieved April 15, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250320145239.htm ...

The prospects for a one-time treatment that reduces the risk of heart disease for the rest of a person’s life just got ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to ... survival and for terminal erythroid differentiation. Gene-edited mouse models are crucial for disease research but remain ...

The recent wave of layoffs and financial troubles at CRISPR-focused startups should not tarnish the promise of CRISPR.

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...